Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients

Sponsor
Medical University of Vienna
Study ID
NCT00822783
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
12 Years - 60 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

Elevated levels of immunoglobuline E in blood are said to promote the occurence of atopic dermatitis; in fact, many patients with atopic dermatitis have high IgE levels. This study tried to explore whether the depletion of IgE from blood and skin might result in a change of immunological parameters and might alter the clinical course of the disease.

Key Dates

Start date
Oct 31, 2001
Status verified
Jan 2009
Completion
Apr 30, 2003

Arms

  • Active Comparator: Omalizumab
  • Placebo Comparator: Placebo

Related Studies